» Articles » PMID: 35812232

Astrocytes in Neurodegeneration: Inspiration From Genetics

Overview
Journal Front Neurosci
Date 2022 Jul 11
PMID 35812232
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the discovery of numerous molecules and pathologies, the pathophysiology of various neurodegenerative diseases remains unknown. Genetics participates in the pathogenesis of neurodegeneration. Neural dysfunction, which is thought to be a cell-autonomous mechanism, is insufficient to explain the development of neurodegenerative disease, implying that other cells surrounding or related to neurons, such as glial cells, are involved in the pathogenesis. As the primary component of glial cells, astrocytes play a variety of roles in the maintenance of physiological functions in neurons and other glial cells. The pathophysiology of neurodegeneration is also influenced by reactive astrogliosis in response to central nervous system (CNS) injuries. Furthermore, those risk-gene variants identified in neurodegenerations are involved in astrocyte activation and senescence. In this review, we summarized the relationships between gene variants and astrocytes in four neurodegenerative diseases, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Parkinson's disease (PD), and provided insights into the implications of astrocytes in the neurodegenerations.

Citing Articles

The characteristic and prognostic role of blood inflammatory markers in patients with Huntington's disease from China.

Xia J, Cheng Y, Zhang S, Ma Y, Fu J, Yang T Front Neurol. 2024; 15:1374365.

PMID: 38595854 PMC: 11002148. DOI: 10.3389/fneur.2024.1374365.


Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson's disease.

Che N, Ou R, Li C, Zhang L, Wei Q, Wang S NPJ Parkinsons Dis. 2024; 10(1):48.

PMID: 38429295 PMC: 10907600. DOI: 10.1038/s41531-024-00664-8.


SRF-deficient astrocytes provide neuroprotection in mouse models of excitotoxicity and neurodegeneration.

Thumu S, Jain M, Soman S, Das S, Verma V, Nandi A Elife. 2024; 13.

PMID: 38289036 PMC: 10857791. DOI: 10.7554/eLife.95577.


Coupling of Alzheimer's Disease Genetic Risk Factors with Viral Susceptibility and Inflammation.

Cao C, Fu G, Xu R, Li N Aging Dis. 2023; 15(5):2028-2050.

PMID: 37962454 PMC: 11346407. DOI: 10.14336/AD.2023.1017.


Plasma glial fibrillary acidic protein as a biomarker of disease progression in Parkinson's disease: a prospective cohort study.

Lin J, Ou R, Li C, Hou Y, Zhang L, Wei Q BMC Med. 2023; 21(1):420.

PMID: 37932720 PMC: 10626747. DOI: 10.1186/s12916-023-03120-1.


References
1.
Yang C, Qiao T, Yu J, Wang H, Guo Y, Salameh J . Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice. PLoS One. 2022; 17(2):e0255710. PMC: 8812852. DOI: 10.1371/journal.pone.0255710. View

2.
Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

3.
Salcedo C, Andersen J, Vinten K, Pinborg L, Waagepetersen H, Freude K . Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's Disease. Front Aging Neurosci. 2021; 13:736580. PMC: 8484639. DOI: 10.3389/fnagi.2021.736580. View

4.
Granatiero V, Sayles N, Savino A, Konrad C, Kharas M, Kawamata H . Modulation of the IGF1R-MTOR pathway attenuates motor neuron toxicity of human ALS SOD1 astrocytes. Autophagy. 2021; 17(12):4029-4042. PMC: 8726657. DOI: 10.1080/15548627.2021.1899682. View

5.
Smethurst P, Risse E, Tyzack G, Mitchell J, Taha D, Chen Y . Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Brain. 2020; 143(2):430-440. PMC: 7009461. DOI: 10.1093/brain/awz419. View